NIH waxay shaqaaleysiiyaan Bukaanada Hypothyroid ee Daraasadda Cusub
Waa maalin farxad leh oo loogu talagalay bukaannada tayroodhka, iyo mid ka mid ah muddo dheer sugayay. Machadka Qaran ee Caafimaadka Mareykanka ayaa ku dhawaaqay in tijaabada caafimaad ee sanadkan 2012 la bilaabay Xarunta Caafimaadka Qaranka ee Walter Reed, ee Bethesda, MD, si loo baaro daawooyinka tayroodhka dabiiciga ah ee loo yaqaan 'levothyroxine', ee loogu talagalay daaweynta hypothyroidism primary.
Daraasada la kala soocay, oo la mariyo Maajo 2014 - waxay qiimeyn doontaa qiyaasta bukaanka qaba hypothyroid on tayroodhka dabiiciga ah (waxa ay ku tilmaamaan "soo-saarista tirtiraha" ama "DTE") waxay yeelan karaan "hoos u dhaca calaamadaha, kor u kaca howlaha garashada, iyo kororka dareenka fiicnaanta / tayada nolosha , "marka la barbar dhigo levothyroxine.
Magaca rasmiga ah ee daraasaddan waa "Qaadashada Tirtiridda ee La Qaadanayo Marka La barbardhigo Levothyroxine ee Daaweynta Hypothyroidism : A Random, Double-blind, Study Crossover," iyo waxay qorayaan bukaannada tirakoobka sida ka qaybgalayaasha daraasadda.
U qalmida
Waxaad xaq u leedahay inaad kaqaybqaadato daraasaddan haddii aad tahay nin ama naag, inta u dhaxaysa 18 ilaa 65 sano. waxayna ku jireen levotyroxine oo loogu talagalay hypothyroidism ugu yaraan 6 bilood. (FIIRO GAAR AH: Xubnaha milateriga oo kaliya ama ka hawlgabay milkiilayaasha iyo ka-faa'iideystayaashooda waxay xaq u leeyihiin tijaabadan.)Diidmada
Waxaa lagaa saari doonaa daraasadda haddii aad leedahay mid ka mid ah xaaladaha ama arrimaha soo socda:- uurka ama qorshaha uurka 12-ka bilood ee soo socda
- cudurrada wadnaha , gaar ahaan cudurka halbowlaha wadnaha
- Cudurka sambabada ee joogtada ah
- xanuunka malabsorption
- qalliinnada mindhicirka
- xannuun weyn oo ka yimaada beerka ama beerka
- xanuunka qallalka
- kansarrada firfircoon ee tayroodh iyo kuwa aan tirtirnayn
- Dhibaato aan la xakameynin
- isticmaalka daawada nafsaaniga ah
- isticmaalka steroid
- isticmaalka amiodarone
- Kiimiko daaweynta kansarka
- Kudar birta ka badan 325mg maalintii
- isticmaalka mashiinka carafate / proton tuubo
- isticmaalka cholestyramine
Maxay Tahay Maxay Tahay Muhiim?
Dacwadani waa muhiim sababtoo ah waa markii ugu horeysay ee taariikhda dhowaan aan ogaado in hay'ad cilmi-baaris caafimaad oo qaran ahaan loo aqoonsan yahay - kiiskan, Machadyada Qaranka ee Caafimaadka ee Maraykanka - ayaa sameeya laba-indhoole, is-dhaafsiin cilmi baaris ah si loo isbarbardhigo calaamadaha, waxqabadka fahamka, fayoobaanta, iyo tayada nolosha ee dadka bukaanka qaba hypothyroid ee daawooyinka tayroodhka dabiiciga ah , oo ka soo horjeeda levothyroxine.Tijaabadani sidoo kale waa muhiim sababtoo ah waxaa jira foorjar xoog leh oo ka dhexjirta takhaatiirta qanjirada caadiga ah ee ka hortagga daaweynta dabiiciga ah, Qaar ka mid ah daawooyinka dheef-shiid kiimikaadka , dhab ahaantii, ayaa xitaa sheegay in daawooyinka tayroodhka ee sida Armor kaliya ay qaadaan "fareemka" , inkastoo xaqiiqda ah in in ka badan laba milyan oo daawo oo dawooyinkaas loo qoro sanad kasta oo ku yaal Maraykanka, dunida.
Tijaabadani sidoo kale waa muhiim sababtoo ah waxaan u baahanahay cilmi-baaris oo si gaar ah u eegaya isticmaalka dabiiciga ah ee dabiiciga ah. Daraasadaha qaarkood, oo ay ku jiraan daraasadda deenishka ee 2009 , ayaa muujisay tayada waxqabadka nolosha, iyadoo lagu darayo T3-da T3 (levotyroxine), laakiin qaar ka mid ah dhakhaatiirta ayaa sheegay, in daraasaddan aanay ku habboonayn marka la tixgelinayo daawooyinka dabiiciga ah ee loo yaqaan 'tyroid drugs' (oo dabiici ah T3 iyo T4 ) sababtoo ah waxay yihiin daroogo kala duwan.
Si aad uga qayb gasho tijaabada
Haddii aad la kulanto shahaadooyinka oo aad xiiseyneyso in lagugu qoro si aad uga qayb qaadato tijaabadan bukaan-socodka, la xiriir: Mohamed Shakir, MD, 301-295-5165, mohamed.shakir@med.navy.mil iyo Patrick Clyde, MD, 301-295- 5165, patrick.clyde@med.navy.mil.Nambarka aqoonsiga ee Trials.gov ee tijaabadan waa NCT01739972.
Waxaad arki kartaa liiska "ClinicalTrials.gov" oo dhan.